This article has been updated to correct an explanation of how the test works versus the current standard of care.

NEW YORK (GenomeWeb) – Molecular diagnostics firm Transplant Genomics today announced that its TruGraf post-kidney transplant blood tests have been accepted for use by four transplant centers under an early-access program — California Pacific Medical Center, the Henry Ford Health System, Houston Methodist Hospital, and the University of Wisconsin.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers find that a personalized medicine approach could help people who experience pain while taking statins, New Scientist reports.

US National Science Foundation is continuing its responsible research conduct training policy despite its flaws, ScienceInsider reports.

A CRISPR-themed meeting explored how the tool could and should be used, Wired reports.

In Science this week: database of proteins' effects on cancer, targeted error correction sequencing, and more.